First Time Loading...

Journey Medical Corp
NASDAQ:DERM

Watchlist Manager
Journey Medical Corp Logo
Journey Medical Corp
NASDAQ:DERM
Watchlist
Price: 3.5 USD -5.15%
Updated: May 1, 2024
Section:
 

Wall Street
Price Targets

DERM Price Targets Summary
Journey Medical Corp

Wall Street analysts forecast DERM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DERM is 7.99 USD with a low forecast of 7.07 USD and a high forecast of 8.93 USD.

DERM Lowest Forecast
Wall Street Target
7.07 USD
102% Upside
DERM Average Forecast
Wall Street Target
7.99 USD
128% Upside
DERM Highest Forecast
Wall Street Target
8.93 USD
155% Upside
Lowest
Price Target
7.07 USD
102% Upside
Average
Price Target
7.99 USD
128% Upside
Highest
Price Target
8.93 USD
155% Upside
Journey Medical Corp Competitors:
Price Targets
002422
Sichuan Kelun Pharmaceutical Co Ltd
17% Upside
Y
002019
Yifan Pharmaceutical Co Ltd
24% Upside
002317
Guangdong Zhongsheng Pharmaceutical Co Ltd
51% Downside
STAR
Strides Pharma Science Ltd
5% Downside
002422
Sichuan Kelun Pharmaceutical Co Ltd
17% Upside
Y
002019
Yifan Pharmaceutical Co Ltd
24% Upside
002317
Guangdong Zhongsheng Pharmaceutical Co Ltd
51% Downside
STAR
Strides Pharma Science Ltd
5% Downside
NEU
Neuren Pharmaceuticals Ltd
43% Upside
VETO
Vetoquinol SA
16% Upside
530477
Vikram Thermo (India) Ltd
67% Downside
600276
Jiangsu Hengrui Pharmaceuticals Co Ltd
25% Upside

Revenue
Forecast

Revenue Estimate
Journey Medical Corp

For the last 3 years the compound annual growth rate for Journey Medical Corp's revenue is 21%. The projected CAGR for the next 3 years is 1%.

21%
Past Growth
1%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Journey Medical Corp

For the last 3 years the compound annual growth rate for Journey Medical Corp's operating income is -49%.

-49%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Journey Medical Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

See Also

Summary
DERM intrinsic value, competitors valuation, and company profile.
DCF Valuation
DERM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DERM stock valuation using valuation multiples.
Wall Street Estimates
DERM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DERM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DERM's stock price target?
Price Target
7.99 USD

According to Wall Street analysts, the average 1-year price target for DERM is 7.99 USD with a low forecast of 7.07 USD and a high forecast of 8.93 USD.

What is Journey Medical Corp's Revenue forecast?
Projected CAGR
1%

For the last 3 years the compound annual growth rate for Journey Medical Corp's revenue is 21%. The projected CAGR for the next 3 years is 1%.

ALPHA SPREAD
Join more than 133,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.